PATENT CLAIM ANALYSIS

Application Number: 15780954
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
The invention relates to the field of analgesics. According to the invention, a kit or composition, particularly a pharmaceutical composition or a pharmaceutical kit, is provided, comprising a nanocarrier which is a hyperbranched polymer, such as a dendritic polymer or dendrimer, preferably having a molecular weight of 1,000-100,000 g/mol, and an analgesic which, when administered without nanocarrier, has both peripheral and central analgesic effect, preferably an opioid such as nalbuphine. According to the invention, the analgesic in this composition mainly or exclusively has a peripheral effect and thus reduces side effects triggered by the activation of central or intestinal opioid receptors. It is used for the treatment of peripheral pain and/or inflammation. The invention also relates to particularly suitable nanocarriers.

Claim (Index 16):
The method of  claim 12 , wherein the composition is administered by intravenous, intramuscular, intraperitoneal, subcutaneous, pulmonary or dermal administration.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.94286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13640842', '13651124', '14084424', '14239461', '12428395']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7343464769723439
- 35 USC 102 Novelty (BERT): 0.4949863285908598
- Combined Prediction Score: 0.7104104621341955
- Mean Citation Score: 190.16621
- Max Citation Score: 193.85817
- Similarity Product: 123.9532384690404

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test